https://az3146inhibitor.com/ar....chitectural-characte
CD10-positive staining was identified in 36.7% and 66.7% of low and high-grade tumors, correspondingly. There was clearly a link between positive CD10 immunostaining and large tumor level ( In UBC, CD10 immunoexpression is involving greater tumefaction level and muscle mass invasion, but it is not associated with patient success or other clinicopathological parameters. CD10 immunoexpression may not be utilized as a biomarker for bad prognosi
Aimer
Commentaire
Partagez
